ArticleJournal of biomedical science2022

Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.

Chih-Hsiung Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.